Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Acad Med. 2017 Oct;92(10):1440–1448. doi: 10.1097/ACM.0000000000001871

Table 2.

Logistic Regression Models Testing the Association Between Race/Ethnicity (Non-URM vs URM) and Each Potential Categorical Mediator Among U.S. Medical School Graduates in 1997—2004 Who Planned Research-related Careers (N =27,521)a

Potential categorical mediators Adjusted odds ratio
(95% confidence interval)b
Research-intensive medical school (yes vs. no) 1.23 (1.14 – 1.32)
Medical school research elective (yes vs. no) 1.12 (1.03 – 1.21)
Medical school authorship (yes vs. no) 1.41 (1.31 – 1.52)
Degree program (each vs. MD degree)
 MD-other advanced degree 0.85 (0.65 – 1.11)
 MD-PhD 1.55 (1.22 – 1.97)
Total debt (each vs. no debt)
 ≥ $100,000 0.42 (0.37 – 0.48)
 $50,000 – $99,999 0.38 (0.34 – 0.44)
 $1 – $49,999 0.47 (0.40 – 0.54)
Specialty choice (each vs. internal medicine)
 Family medicine 0.49 (0.39 – 0.61)
 Pediatrics 0.94 (0.82 – 1.08)
 Obstetrics-gynecology 0.52 (0.44 – 0.60)
 No/undecided about board certification 0.82 (0.70 – 0.97)
 Surgery specialties 0.73 (0.66 – 0.82)
 All other specialties 0.88 (0.80 – 0.98)
≥ 1 GME research year (yes vs. no) 1.30 (1.19 – 1.43)
F32 award (yes vs. no) 1.94 (1.23 – 3.06)

Abbreviations: URM indicates underrepresented minorities in medicine; GME, graduate medical education.

a

This table provides the adjusted odds ratio data for the relationship described in Path A of Figure 1 between race/ethnicity and each potential mediator.

b

Each model is adjusted for sex and graduation year. An adjusted odds ratio (aOR) < 1.00 indicates, for example, that non-URM (vs. URM) graduates were less likely to report ≥ $100,000 total debt at graduation (vs. no debt). An aOR > 1.00 indicates, for example, that non-URM (vs. URM) graduates were more likely to have attended a research-intensive medical school. If 95% confidence intervals include the value 1.00, the associated aORs are not statistically significant.